Christine Lee, PhD
Personal Statement
The transition to adulthood is the developmental period when alcohol use, marijuana use, and their associated consequences reach their lifetime peak. My scholarly interests focus on the etiology and prevention of substance use behaviors and consequences during adolescence and young/early adulthood. I have developed a highly successful portfolio of work bridging developmental, social, and motivational theory with applied prevention and intervention techniques to strategically address high-risk behaviors during the transition to adulthood. My research addresses important questions regarding how recent marijuana legislation in Washington State impacts young adult marijuana use and consequences; what motivates young adults to engage in alcohol and marijuana use; how alcohol expectancies, alcohol use and consequences are linked in a natural feed-forward process that maintains high-risk behaviors; how developmental transitions and event timing influence use; and what are efficacious prevention and intervention strategies and for whom and under what conditions are these most effective.Department Affiliations
Scholarly Expertise
- Project RELATE
- Alcohol-focused Support of Survivors In Sororities Training (ASSIST)
- THRIVE Study
- Reducing barriers to accessing mental health care using a web-based program for young adults
- COVID-19 Student Survey
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) Outreach Communications Support
- Development of an interactive, web-based drinking to cope intervention and tools to assess coping skill utilization
- Affective Dynamics Associated with Simultaneous Alcohol and Marijuana Use Outcomes among a High-risk Sample of Young Adults
- Project Reflect
- Young Adult Riding and Driving Study (YARD)
- Harm reduction in the context of social distancing
- Project ACE
- Project Transitions
- The Teen Identity Project (TIP)
- Project AMPS
- Project SAM Transitions
Recent Publications
Pharmacokinetic profiling of limnetrelvir in non-Japanese and Japanese populations: results of two phase 1 single- and multiple-dose studies.
(2026 Mar 23)
Antimicrob Agents Chemother
Chowdhury EA, Lee CM, Desai JM, Ali I, Orejudos A, Gupta SV, Ocampo CJ, Miller MG, Jayanth J, Schmidt JM, Salem AH, Mostafa NM
(2026 Mar 23)
Antimicrob Agents Chemother
Chowdhury EA, Lee CM, Desai JM, Ali I, Orejudos A, Gupta SV, Ocampo CJ, Miller MG, Jayanth J, Schmidt JM, Salem AH, Mostafa NM
Tracheostomy vs. Delayed Extubation in Head and Neck Reconstruction: A Meta-Analysis.
(2026 Mar 19)
Laryngoscope
Goel S, Lee C, Lin K, Pryor L, Ludbrook G, Foreman A, Hodge JC
(2026 Mar 19)
Laryngoscope
Goel S, Lee C, Lin K, Pryor L, Ludbrook G, Foreman A, Hodge JC
Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.
(2026 Mar 18)
JAMA Dermatol
Kimball AB, Sawicki KT, Ackerman L, Lima H, Giamarellos-Bourboulis EJ, Zhan T, Drogaris L, Gu Y, Lee CM, Akbari M, Williams DA, Bechara FG
(2026 Mar 18)
JAMA Dermatol
Kimball AB, Sawicki KT, Ackerman L, Lima H, Giamarellos-Bourboulis EJ, Zhan T, Drogaris L, Gu Y, Lee CM, Akbari M, Williams DA, Bechara FG
Building safeguards for gene therapy in haemophilia.
(2026 Mar 10)
Lancet Haematol
Uminski K, Lee CA, Hermans C
(2026 Mar 10)
Lancet Haematol
Uminski K, Lee CA, Hermans C
Cannabis Use Problems Moderate Daily Associations between Cannabis Consequences and Subsequent Use.
(2026 Mar 10)
J Stud Alcohol Drugs
Dyar C, Rhew IC, Lee CM
(2026 Mar 10)
J Stud Alcohol Drugs
Dyar C, Rhew IC, Lee CM
Show complete publication list »
